0000899243-22-015764.txt : 20220427 0000899243-22-015764.hdr.sgml : 20220427 20220427160535 ACCESSION NUMBER: 0000899243-22-015764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220426 FILED AS OF DATE: 20220427 DATE AS OF CHANGE: 20220427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golumbeski George CENTRAL INDEX KEY: 0001586660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 22859508 MAIL ADDRESS: STREET 1: C/O CELGENE CORP. STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-26 0 0001680367 Shattuck Labs, Inc. STTK 0001586660 Golumbeski George C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 1 0 0 0 Common Stock 2022-04-26 4 P 0 28330 3.63 A 54613 D This transaction was executed in multiple trades at prices ranging from $3.505 to $3.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Erin Ator Thomson, Attorney-in-Fact for George Golumbeski 2022-04-27